Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler
Authors:
- J P KarpelJKJ P Karpel
- G W BenschGBG W Bensch
- J W RamsdellJRJ W Ramsdell
- D R WebbDWD R Webb
- K B NolopKNK B Nolop
- B N LutskyBLB N Lutsky
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 86 (1) , 36-43
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthmaAnnals of Allergy, Asthma & Immunology, 2000
- DIURNAL RHYTHMS OF PRO-INFLAMMATORY CYTOKINES: REGULATION BY PLASMA CORTISOL AND THERAPEUTIC IMPLICATIONSCytokine, 1998
- Mometasone FuroateDrugs, 1998
- Nonadherence in Asthmatic Patients: Is there a Solution to the Problem ?Annals of Allergy, Asthma & Immunology, 1997
- A comparison of the efficacy and safety of inhaled corticosteroids in asthmaAllergy, 1997
- Once Daily Mometasone Furoate Aqueous Nasal Spray Is As Effective as Twice Daily Beclomethasone Dipropionate for Treating Perennial Allergic Rhinitis PatientsAnnals of Allergy, Asthma & Immunology, 1996
- 62 Lack of systemic activity with intranasal mometasone furoateJournal of Allergy and Clinical Immunology, 1996
- Chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacyJournal of Allergy and Clinical Immunology, 1995
- Measuring compliance with inhaled medication in asthma.Archives of Disease in Childhood, 1992
- Circadian Basis of the Late Asthmatic ResponseAmerican Review of Respiratory Disease, 1990